ririРаны и раневые инфекции. Журнал имени проф. Б.М. КостючёнкаWounds and wound infections. The prof. B.M. Kostyuchenok journal2408-96132500-0594Regional non-governmental organization “Surgical society - Wounds and wound infections”10.25199/2408-9613-2024-11-1-6-20riri-315Research ArticleОБЗОРЫ, ЛЕКЦИИ, ИСТОРИЯ РАН И РАНЕВЫХ ИНФЕКЦИЙREVIEWS, LECTURES, HISTORY OF WOUNDS AND WOUND INFECTIONSАтипичные раны (обзор литературы)Atypical wounds (a literature review)https://orcid.org/0000-0002-7851-3813БорисовИ. В.BorisovI. V.

Борисов Игорь Викторович – доктор медицинских наук, заведующий кабинетом диабетической стопы отдела ран и раневых инфекций, доцент кафедры медицины катастроф

117997, Москва, ул. Большая Серпуховская, д. 27

117198, Москва, ул. Миклухо-Маклая, д. 8

Igor V. Borisov – MD, Dr. Sc. (Med.), Head of Diabetic Foot Office in Wounds and Wound Infections Department; Associate Professor at the Department of Disaster Medicine

27 Bolshaya Serpukhovskaya Str., Moscow, 117997

8 Miklukho-Maklaya Str., Moscow, 117198

boris-62@list.ruhttps://orcid.org/0000-0001-6411-0709МитишВ. А.MitishV. A.

Митиш Валерий Афанасьевич – кандидат медицинских наук, доцент, заведующий отделом ран и раневых инфекций, заведующий кафедрой медицины катастроф

117997, Москва, ул. Большая Серпуховская, д. 27

117198, Москва, ул. Миклухо-Маклая, д. 8

Valery A. Mitish – MD, Candidate of Medical Sciences, Associate Professor, Head of the Department of Wounds and Wound Infections; Head of the Department of Disaster Medicine

27 Bolshaya Serpukhovskaya Str., Moscow, 117997

8 Miklukho-Maklaya Str., Moscow, 117198

https://orcid.org/0000-0003-1215-8035ПасхаловаЮ. С.PaskhalovaYu. S.

Пасхалова Юлия Сергеевна – кандидат медицинских наук, старший научный сотрудник отдела ран и раневых инфекций, доцент кафедры медицины катастроф

117997, Москва, ул. Большая Серпуховская, д. 27

117198, Москва, ул. Миклухо-Маклая, д. 8

Yulia S. Paskhalova – MD, Candidate of Medical Sciences, Senior Researcher at the Department of Wounds and Wound Infections; Associate Professor of the Department of Disaster Medicine

27 Bolshaya Serpukhovskaya Str., Moscow, 117997

8 Miklukho-Maklaya Str., Moscow, 117198

https://orcid.org/0009-0006-0471-1047Ронкильо ЗамораВ. М.Ronquillo ZamoraV. M.

Ронкильо Замора Ванесса Маделина – ассистент кафедры медицины катастроф

117198, Москва, ул. Миклухо-Маклая, д. 8

Vanessa Madelyne Ronquillo Zamora – MD, assistant at the Department of Disaster Medicine

8 Miklukho-Maklaya Str., Moscow, 117198

ФГБУ «Национальный медицинский исследовательский центр хирургии им. А. В. Вишневского» Минздрава России ; ФГАОУ ВО «Российский университет дружбы народов им. Патриса Лумумбы» Минобрнауки РоссииРоссияA. V. Vishnevsky National Medical Research Center of Surgery ; Patrice Lumumba Peoples’ Friendship University of Russia, Ministry of Education and Science of Russian FederationRussian FederationФГАОУ ВО «Российский университет дружбы народов им. Патриса Лумумбы» Минобрнауки РоссииРоссияPatrice Lumumba Peoples’ Friendship University of Russia, Ministry of Education and Science of Russian FederationRussian Federation202412082024111620Copyright © Борисов И.В., Митиш В.А., Пасхалова Ю.С., Ронкильо Замора В.M., 20242024Борисов И.В., Митиш В.А., Пасхалова Ю.С., Ронкильо Замора В.Borisov I.V., Mitish V.A., Paskhalova Y.S., Ronquillo Zamora V.M.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.riri.su/jour/article/view/315

В статье представлен обзор литературы, посвященный проблеме диагностики и лечения атипичных ран. Обсуждаются вопросы важности хирургической настороженности при отсутствии ответа на стандартное лечение в течение 4 и более нед, необходимости тканевой биопсии и мультидисциплинарного подхода при подозрении на атипичный характер этиологии и патогенеза длительно незаживающих ран.

The article presents a review on the problem of diagnosis and treatment of atypical wounds. The authors highlight the importance of surgical vigilance in the absence of response to standard treatment for 4 weeks or more, the importance of tissue biopsy and multidisciplinary approach, if an atypical etiology and pathogenesis of long-term non-healing wounds are suspected.

атипичные раныхронические раныосложненные инфекции кожи и мягких тканейгнойная ранагнойно-некротический очагхирургическая инфекциядиагностикадифференциальная диагностикахирургическое лечениеместное лечениеatypical woundschronic woundscomplicated infectionsskin and soft tissues infectionspurulent woundpurulent-necrotic focussurgical infectiondiagnosisdifferential diagnosissurgical treatmentlocal treatmentReferencesSitum M., Kolić M., Redzepi G., Antolić S. Chronic wounds as a public health problem. Acta Med Croatica. 2014; 68 (Suppl 1): 5–7.Situm M., Kolić M., Redzepi G., Antolić S. Chronic wounds as a public health problem. Acta Med Croatica. 2014; 68 (Suppl 1): 5–7.Sen C. K. Human wound and its burden: updated 2020 compendium of estimates. Adv Wound Care. 2021; 10(5): 281–292.Sen C. K. Human wound and its burden: updated 2020 compendium of estimates. Adv Wound Care. 2021; 10(5): 281–292.Körber A., Klode J., Al‐Benna S., et al. Etiology of chronic leg ulcers in 31,619 pa- tients in Germany analyzed by an expert survey. J Dtsch Dermatol Ges. 2011; 9 (2): 116– 121.Körber A., Klode J., Al‐Benna S., et al. Etiology of chronic leg ulcers in 31,619 pa- tients in Germany analyzed by an expert survey. J Dtsch Dermatol Ges. 2011; 9 (2): 116– 121.Nickles M. A., Tsoukas M. M., Sweiss N., et al. Atypical ulcers: a stepwise approach for clinicians. Wounds. 2022; 34 (10): 236–244.Nickles M. A., Tsoukas M. M., Sweiss N., et al. Atypical ulcers: a stepwise approach for clinicians. Wounds. 2022; 34 (10): 236–244.Isoherranen K., O’Brien J. J., Barker J., et al. Atypical wounds. Best clinical practice and challenges. J Wound Care. 2019; 28 (Sup- pl 6): 1–92.Isoherranen K., O’Brien J. J., Barker J., et al. Atypical wounds. Best clinical practice and challenges. J Wound Care. 2019; 28 (Sup- pl 6): 1–92.Virkkala J., Polet S., Jokelainen J., et al. Clinical characteristics and comorbidities of the most common atypical wounds in Northern Finland in 1996-2019: A retrospective registry study. Health Sci Rep. 2022; 5 (5): e864.Virkkala J., Polet S., Jokelainen J., et al. Clinical characteristics and comorbidities of the most common atypical wounds in Northern Finland in 1996-2019: A retrospective registry study. Health Sci Rep. 2022; 5 (5): e864.Shanmugam V. K., Angra D., Rahimi H., McNish S. Vasculitic and autoimmune wounds. J Vasc Surg Venous Lymphat Disord. 2017; 5 (2): 280–292.Shanmugam V. K., Angra D., Rahimi H., McNish S. Vasculitic and autoimmune wounds. J Vasc Surg Venous Lymphat Disord. 2017; 5 (2): 280–292.Tang J. C., Vivas A., Rey A., et al. Atypical ulcers: wound biopsy results from a university wound pathology service. Ostomy Wound Manage. 2012; 58 (6): 20–22, 24, 26–29.Tang J. C., Vivas A., Rey A., et al. Atypical ulcers: wound biopsy results from a university wound pathology service. Ostomy Wound Manage. 2012; 58 (6): 20–22, 24, 26–29.Janowska A., Dini V., Oranges T., et al. Atypical ulcers: diagnosis and management. Clin Interv Aging. 2019; 14: 2137–2143.Janowska A., Dini V., Oranges T., et al. Atypical ulcers: diagnosis and management. Clin Interv Aging. 2019; 14: 2137–2143.Kluger N., Koljonen V., Senet P. Martorell ulcer. Duodecim. 2013; 129 (10): 1031–1036.Kluger N., Koljonen V., Senet P. Martorell ulcer. Duodecim. 2013; 129 (10): 1031–1036.Ansert E., Tickner A., Cohen D., et al. Understanding the zebras of wound care: an overview of atypical wounds. Wounds. 2022; 34 (5): 124–134.Ansert E., Tickner A., Cohen D., et al. Understanding the zebras of wound care: an overview of atypical wounds. Wounds. 2022; 34 (5): 124–134.Hamm R. L., Shah J. B. Atypical wounds. In: Text and Atlas of Wound Diagnosis and Treatment. Hamm R. L., ed. 2nd edn. McGraw-Hill Education; 2019.Hamm R. L., Shah J. B. Atypical wounds. In: Text and Atlas of Wound Diagnosis and Treatment. Hamm R. L., ed. 2nd edn. McGraw-Hill Education; 2019.Хэмм Р. Л. Раны. Диагностика и лечение. Атлас-справочник. Глава 8. Атипичные раны. М.: ГЭОТАР-Медиа, 2023.Hamm R. L. Text and Atlas of Wound Diagnosis and Treatment. Ch. 8. Atypical wounds = Khemm R.L. Rany. Diagnostika i lecheniye. Atlas-spravochnik. Glava 8. Atipichnyye rany. M.: GEOTAR-Media, 2023. (In Russ.)Singer A. J., Tassiopoulos A., Kirsner R. S. Evaluation and management of lower-extremity ulcers. N Engl J Med. 2017; 377 (16): 1559–1567.Singer A. J., Tassiopoulos A., Kirsner R. S. Evaluation and management of lower-extremity ulcers. N Engl J Med. 2017; 377 (16): 1559–1567.Stevenson P., Rodins K. Improving diagnostic accuracy of skin biopsies. Aust J Gen Pract. 2018; 47 (4): 216–220.Stevenson P., Rodins K. Improving diagnostic accuracy of skin biopsies. Aust J Gen Pract. 2018; 47 (4): 216–220.Elston D. M., Stratman E. J., Miller S. J. Skin biopsy: biopsy issues in specific diseases. J Am Acad Dermatol. 2016; 74 (1): 1–16.Elston D. M., Stratman E. J., Miller S. J. Skin biopsy: biopsy issues in specific diseases. J Am Acad Dermatol. 2016; 74 (1): 1–16.Compton L. A., Murphy G. F., Lian C. G. Diagnostic immunohistochemistry in cutaneous neoplasia: an update. Dermatopathology (Basel). 2015; 2 (1): 15–42.Compton L. A., Murphy G. F., Lian C. G. Diagnostic immunohistochemistry in cutaneous neoplasia: an update. Dermatopathology (Basel). 2015; 2 (1): 15–42.Patel S., Maheshwari A., Chandra A. Biomarkers for wound healing and their evaluation. J Wound Care. 2016; 25 (1): 46–55.Patel S., Maheshwari A., Chandra A. Biomarkers for wound healing and their evaluation. J Wound Care. 2016; 25 (1): 46–55.Shavit E., Alavi A., Sibbald R.G. Vasculitis-what do we have to know? A review of literature. Int J Low Extrem Wounds. 2018; 17 (4): 218–226.Shavit E., Alavi A., Sibbald R.G. Vasculitis-what do we have to know? A review of literature. Int J Low Extrem Wounds. 2018; 17 (4): 218–226.Riyaz N., Mary V., Sasidharanpillai S., et al. Pyodermagangrenosum: a clinico-epidemiologicalstudy. Indian J Dermatol Venereol Leprol. 2017; 83 (1): 33–39.Riyaz N., Mary V., Sasidharanpillai S., et al. Pyodermagangrenosum: a clinico-epidemiologicalstudy. Indian J Dermatol Venereol Leprol. 2017; 83 (1): 33–39.Stevens D. L, Bisno A. L., Chambers H. F., et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis. 2014; 59 (2): e10–e52.Stevens D. L, Bisno A. L., Chambers H. F., et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis. 2014; 59 (2): e10–e52.Kain R. Histopathology. Methods Mol Biol. 2017; 1508: 185–193.Kain R. Histopathology. Methods Mol Biol. 2017; 1508: 185–193.Alavi A., French L. E., Davis M.D., et al. Pyoderma gangrenosum: an update on pathophysiology, diagnosis and treatment. Am J Clin Dermatol. 2017; 18 (3): 355– 372.Alavi A., French L. E., Davis M.D., et al. Pyoderma gangrenosum: an update on pathophysiology, diagnosis and treatment. Am J Clin Dermatol. 2017; 18 (3): 355– 372.Xu A., Balgobind A., Strunk A., et al. Prevalence estimates for pyoderma gangrenosum in the United States: an ageand sex-adjusted population analysis. J Am Academy Dermatol. 2020; 83 (2): 425–429.Xu A., Balgobind A., Strunk A., et al. Prevalence estimates for pyoderma gangrenosum in the United States: an ageand sex-adjusted population analysis. J Am Academy Dermatol. 2020; 83 (2): 425–429.Ahn C., Negus D., Huang W. Pyoderma gangrenosum: a review of pathogenesis and treatment. Expert Rev Clin Immunol. 2018; 14 (3): 225–233.Ahn C., Negus D., Huang W. Pyoderma gangrenosum: a review of pathogenesis and treatment. Expert Rev Clin Immunol. 2018; 14 (3): 225–233.Braswell S. F., Kostopoulos T. C., Ortega-Loayza A.G. Pathophysiology of pyoderma gangrenosum (PG): An updated review. J Am Academy Dermatol. 2015; 73 (4): 691–698.Braswell S. F., Kostopoulos T. C., Ortega-Loayza A.G. Pathophysiology of pyoderma gangrenosum (PG): An updated review. J Am Academy Dermatol. 2015; 73 (4): 691–698.George C., Deroide F., Rustin M. Pyoderma gangrenosum — a guide to diagnosis and management. Clin Med (Lond). 2019; 19 (3): 224–228.George C., Deroide F., Rustin M. Pyoderma gangrenosum — a guide to diagnosis and management. Clin Med (Lond). 2019; 19 (3): 224–228.Maverakis E., Ma C., Shinkai K., et al. Diagnostic criteria of ulcerative pyoderma gangrenosum: a Delphi consensus of international experts. JAMA Dermatol. 2018; 154 (4): 461–466.Maverakis E., Ma C., Shinkai K., et al. Diagnostic criteria of ulcerative pyoderma gangrenosum: a Delphi consensus of international experts. JAMA Dermatol. 2018; 154 (4): 461–466.Bennett M. L., Jackson J. M., Jorizzo J. L., et al. Pyoderma gangrenosum. A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions. Medicine (Baltimore). 2000; 79 (1): 37–46.Bennett M. L., Jackson J. M., Jorizzo J. L., et al. Pyoderma gangrenosum. A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions. Medicine (Baltimore). 2000; 79 (1): 37–46.Ahronowitz I., Harp J., Shinkai K. Etiology and management of pyoderma gangrenosum. Am J Clin Dermatol. 2012; 13 (3): 191– 211.Ahronowitz I., Harp J., Shinkai K. Etiology and management of pyoderma gangrenosum. Am J Clin Dermatol. 2012; 13 (3): 191– 211.Ashchyan H. J., Butler D. C., Nelson C. A., et al. The association of age with clinical presentation and comorbidities of pyoderma gangrenosum. JAMA Dermatol. 2018; 154 (4): 409–413.Ashchyan H. J., Butler D. C., Nelson C. A., et al. The association of age with clinical presentation and comorbidities of pyoderma gangrenosum. JAMA Dermatol. 2018; 154 (4): 409–413.Fraticelli P., Devis B., Gabrielli A. Diagnosis and management of leukocytoclastic vasculitis. Intern Emerg Med. 2021; 16 (4): 831– 841.Fraticelli P., Devis B., Gabrielli A. Diagnosis and management of leukocytoclastic vasculitis. Intern Emerg Med. 2021; 16 (4): 831– 841.Frumholtz L., Laurent‐Roussel S., Lipsker D., Terrier B. Cutaneous vasculitis: review on diagnosis and clinicopathologic correlations. Clin Rev Allergy Immunol. 2016; 61 (2): 181–193.Frumholtz L., Laurent‐Roussel S., Lipsker D., Terrier B. Cutaneous vasculitis: review on diagnosis and clinicopathologic correlations. Clin Rev Allergy Immunol. 2016; 61 (2): 181–193.Roberto H., Brandt C., Arnone M., et al. Medium and large vessel vasculitis. An Bras Dermatol. 2009; 84 (1): 55–67.Roberto H., Brandt C., Arnone M., et al. Medium and large vessel vasculitis. An Bras Dermatol. 2009; 84 (1): 55–67.Arora A., Wetter D. A., Gonzalez-Santiago T. M., et al. A population‐based study in Olmsted County, Minnesota. Mayo Clin Proc. 1996; 89: 1515–1524.Arora A., Wetter D. A., Gonzalez-Santiago T. M., et al. A population‐based study in Olmsted County, Minnesota. Mayo Clin Proc. 1996; 89: 1515–1524.Watts R. A., Jolliffe V. A., Grattan C. E., et al. Cutaneous vasculitis in a defined population — clinical and epidemiological associations. J Rheumatol. 1998; 25 (5): 920–924.Watts R. A., Jolliffe V. A., Grattan C. E., et al. Cutaneous vasculitis in a defined population — clinical and epidemiological associations. J Rheumatol. 1998; 25 (5): 920–924.Pannier F., Rabe E. Differential diagnosis of leg ulcers. Phlebology. 2013; 28 (Suppl 1): 55–60.Pannier F., Rabe E. Differential diagnosis of leg ulcers. Phlebology. 2013; 28 (Suppl 1): 55–60.De Virgilio A., Greco A., Magliulo G., et al. Polyarteritis nodosa: a contemporary overview. Autoimmunity Rev. 2016; 15 (6): 564– 570.De Virgilio A., Greco A., Magliulo G., et al. Polyarteritis nodosa: a contemporary overview. Autoimmunity Rev. 2016; 15 (6): 564– 570.Morgan A. J., Schwartz R. A. Cutaneous polyarteritis nodosa: a comprehensive review. Int J Dermatol. 2010; 49 (7): 750–756.Morgan A. J., Schwartz R. A. Cutaneous polyarteritis nodosa: a comprehensive review. Int J Dermatol. 2010; 49 (7): 750–756.Martinez-Taboada V. M., Blanco R., Garcia-Fuentes M., Rodriguez-Valverde V. Clinical features and outcome of 95 patients with hypersensitivity vasculitis. Am J Med. 1997; 102 (2): 186–191.Martinez-Taboada V. M., Blanco R., Garcia-Fuentes M., Rodriguez-Valverde V. Clinical features and outcome of 95 patients with hypersensitivity vasculitis. Am J Med. 1997; 102 (2): 186–191.Medhekar S. V., Vasani R. J., Kamath R. R. Leukocytoclastic vasculitis: a window to systemic churgstrauss syndrome. Indian J Dermatol. 2012; 57 (3): 215–218.Medhekar S. V., Vasani R. J., Kamath R. R. Leukocytoclastic vasculitis: a window to systemic churgstrauss syndrome. Indian J Dermatol. 2012; 57 (3): 215–218.Yates M., Watts R. ANCA-associated vasculitis. Clin Med (London). 2017; 17 (1): 60–64.Yates M., Watts R. ANCA-associated vasculitis. Clin Med (London). 2017; 17 (1): 60–64.Ekeigwe N. L., Adelowo O., Anaba E. L., Olaosebikan H. Eosinophilic granulomatosis with polyangiitis in a Nigerian woman. BMJ Case Rep. 2019; 12 (6): e228901.Ekeigwe N. L., Adelowo O., Anaba E. L., Olaosebikan H. Eosinophilic granulomatosis with polyangiitis in a Nigerian woman. BMJ Case Rep. 2019; 12 (6): e228901.Richetta A. G., Mattozzi C., Maiani E., et al. Skin ulcers in a patient afflicted with microscopic polyangiitis. Wounds. 2009; 21 (6): 141–143.Richetta A. G., Mattozzi C., Maiani E., et al. Skin ulcers in a patient afflicted with microscopic polyangiitis. Wounds. 2009; 21 (6): 141–143.Becker R. C. COVID-19-associated vasculitis and vasculopathy. J Thromb Thrombolysis. 2020; 50 (3): 499–511.Becker R. C. COVID-19-associated vasculitis and vasculopathy. J Thromb Thrombolysis. 2020; 50 (3): 499–511.Kolivras A., Dehavay F., Delplace D., et al. Coronavirus (COVID-19) infection-induced chilblains: a case report with histopathologic findings. JAAD Case Rep. 2020; 6 (6): 489–492.Kolivras A., Dehavay F., Delplace D., et al. Coronavirus (COVID-19) infection-induced chilblains: a case report with histopathologic findings. JAAD Case Rep. 2020; 6 (6): 489–492.McGonagle D., Bridgewood C., Ramanan A. V., et al. COVID-19 vasculitis and novel vasculitis mimics. Lancet Rheumatol. 2021; 3 (3): e224–e233.McGonagle D., Bridgewood C., Ramanan A. V., et al. COVID-19 vasculitis and novel vasculitis mimics. Lancet Rheumatol. 2021; 3 (3): e224–e233.Silva F., Pinto C., Barbosa A., et al. New insights in cryoglobulinemic vasculitis. J Autoimmun. 2019; 105: 102313.Silva F., Pinto C., Barbosa A., et al. New insights in cryoglobulinemic vasculitis. J Autoimmun. 2019; 105: 102313.Shanmugam V. K., DeMaria D. M., Attinger C. E. Lower extremity ulcers in rheumatoid arthritis: features and response to immunosuppression. Clin Rheumatol. 2011; 30 (6): 849–853.Shanmugam V. K., DeMaria D. M., Attinger C. E. Lower extremity ulcers in rheumatoid arthritis: features and response to immunosuppression. Clin Rheumatol. 2011; 30 (6): 849–853.Oien R. F., Håkansson A., Hansen B. U. Leg ulcers in patients with rheumatoid arthritis — a prospective study of aetiology, wound healing and pain reduction after pinch grafting. Rheumatol (Oxford). 2001; 40 (7): 816–820.Oien R. F., Håkansson A., Hansen B. U. Leg ulcers in patients with rheumatoid arthritis — a prospective study of aetiology, wound healing and pain reduction after pinch grafting. Rheumatol (Oxford). 2001; 40 (7): 816–820.Hoffman M. D. Atypical ulcers. Dermatol Ther. 2013; 26 (3): 222–235.Hoffman M. D. Atypical ulcers. Dermatol Ther. 2013; 26 (3): 222–235.Dabiri G., Falanga V. Connective tissue ulcers. J Tissue Viability. 2013; 22 (4): 92–102.Dabiri G., Falanga V. Connective tissue ulcers. J Tissue Viability. 2013; 22 (4): 92–102.Shanmugam V. K., Price P., Attinger C. E., Steen V. D. Lower extremity ulcers in systemic sclerosis: features and response to therapy. Int J Rheumatol. 2010; 2010: 747946.Shanmugam V. K., Price P., Attinger C. E., Steen V. D. Lower extremity ulcers in systemic sclerosis: features and response to therapy. Int J Rheumatol. 2010; 2010: 747946.Yoo S. S., Mimouni D., Nikolskaia O. V., et al. Clinicopathologic features of ulcerativeatrophic sarcoidosis. Int J Dermatol. 2004; 43 (2): 108–112.Yoo S. S., Mimouni D., Nikolskaia O. V., et al. Clinicopathologic features of ulcerativeatrophic sarcoidosis. Int J Dermatol. 2004; 43 (2): 108–112.Hashemi D. A., Rosenbach M. Ulcerative sarcoidosis. JAMA Dermatology. 2019; 155 (2): 238–238.Hashemi D. A., Rosenbach M. Ulcerative sarcoidosis. JAMA Dermatology. 2019; 155 (2): 238–238.Alhameedy M. M. Necrobiosis lipoidica: atypical presentation in a diabetic girl. Case Rep Dermatol. 2021; 13 (3): 547–552.Alhameedy M. M. Necrobiosis lipoidica: atypical presentation in a diabetic girl. Case Rep Dermatol. 2021; 13 (3): 547–552.Marcoval J., Gómez-Armayones S., Valentí-Medina F., et al. Necrobiosis lipoidica: a descriptive study of 35 cases. Actas Dermosifiliogr. 2015; 106 (5): 402–407.Marcoval J., Gómez-Armayones S., Valentí-Medina F., et al. Necrobiosis lipoidica: a descriptive study of 35 cases. Actas Dermosifiliogr. 2015; 106 (5): 402–407.Nandeesh B., Tirumalae R. Direct immunofluorescence in cutaneous vasculitis: experience from a referral hospital in India. Indian J Dermatol. 2013; 58 (1): 22–25.Nandeesh B., Tirumalae R. Direct immunofluorescence in cutaneous vasculitis: experience from a referral hospital in India. Indian J Dermatol. 2013; 58 (1): 22–25.Sais G., Vidaller A., Jucglà A., et al. Prognostic factors in leukocytoclastic vasculitis: a clinicopathologic study of 160 patients. Arch Dermatol. 1998; 134 (3): 309–315.Sais G., Vidaller A., Jucglà A., et al. Prognostic factors in leukocytoclastic vasculitis: a clinicopathologic study of 160 patients. Arch Dermatol. 1998; 134 (3): 309–315.Harvey N., Chan J., Wood B. Skin biopsy in the diagnosis of inflammatory skin disease. Aust Fam Physician. 2017; 46 (5): 283–288.Harvey N., Chan J., Wood B. Skin biopsy in the diagnosis of inflammatory skin disease. Aust Fam Physician. 2017; 46 (5): 283–288.Carlson J. A. The histological assessment of cutaneous vasculitis. Histopathology. 2010; 56 (1): 3–23.Carlson J. A. The histological assessment of cutaneous vasculitis. Histopathology. 2010; 56 (1): 3–23.Suresh E. Diagnostic approach to patients with suspected vasculitis. Postgrad Med J. 2006; 82 (970): 483–488.Suresh E. Diagnostic approach to patients with suspected vasculitis. Postgrad Med J. 2006; 82 (970): 483–488.Luqmani R. A., Pathare S., Kwok-Fai T. L. How to diagnose and treat secondary forms of vasculitis. Best Pract Res Clin Rheumatol. 2005; 19 (2): 321–336.Luqmani R. A., Pathare S., Kwok-Fai T. L. How to diagnose and treat secondary forms of vasculitis. Best Pract Res Clin Rheumatol. 2005; 19 (2): 321–336.Baigrie D., Goyal A., Crane J. S. Leukocytoclastic Vasculitis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024.Baigrie D., Goyal A., Crane J. S. Leukocytoclastic Vasculitis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024.Tilley C. P., Fu M. R., Van Cleeve J., et al. Symptoms of malignant fungating wounds and functional performance among patients with advanced cancer: an integrative review from 2000 to 2019. J Palliat Med. 2020; 23 (6): 848–862.Tilley C. P., Fu M. R., Van Cleeve J., et al. Symptoms of malignant fungating wounds and functional performance among patients with advanced cancer: an integrative review from 2000 to 2019. J Palliat Med. 2020; 23 (6): 848–862.Trent J. T, Kirsner R. S. Wounds and malignancy. Adv Skin Wound Care. 2003; 16 (1): 31–34.Trent J. T, Kirsner R. S. Wounds and malignancy. Adv Skin Wound Care. 2003; 16 (1): 31–34.Altunay I., Çerman A. A., Sakiz D., Ates B. Marjolin’s ulcer presenting with intransit metastases: a case report and literature review. Ann Dermatol. 2015; 27 (4): 442– 445.Altunay I., Çerman A. A., Sakiz D., Ates B. Marjolin’s ulcer presenting with intransit metastases: a case report and literature review. Ann Dermatol. 2015; 27 (4): 442– 445.Miot H. A., Miot L. D., da Costa A. L., et al. Association between solitary keratoacanthoma and cigarette smoking: a case-control study. Dermatol Online J. 2006; 12 (2): 2.Miot H. A., Miot L. D., da Costa A. L., et al. Association between solitary keratoacanthoma and cigarette smoking: a case-control study. Dermatol Online J. 2006; 12 (2): 2.Elkins-Williams S. T., Marston W. A., Hultman C. S. Management of the chronic burn wound. Clin Plast Surg. 2017; 44 (3): 679–687.Elkins-Williams S. T., Marston W. A., Hultman C. S. Management of the chronic burn wound. Clin Plast Surg. 2017; 44 (3): 679–687.Martinez-Mera C., Fraga J., Capusan T. M., et al. Vasculopathies, cutaneous necrosis and emergency in dermatology. G Ital Dermatol Venereol. 2017; 152 (6): 615–637.Martinez-Mera C., Fraga J., Capusan T. M., et al. Vasculopathies, cutaneous necrosis and emergency in dermatology. G Ital Dermatol Venereol. 2017; 152 (6): 615–637.Siddiqi H. K., Libby P., Ridker P. M. COVID-19 — A vascular disease. Trends Cardiovasc Med. 2021; 31 (1): 1–5.Siddiqi H. K., Libby P., Ridker P. M. COVID-19 — A vascular disease. Trends Cardiovasc Med. 2021; 31 (1): 1–5.Jacobs-Kosmin D., DeHoratius R.J. Calciphylaxis: An important imitator of cutaneous vasculitis. Arthritis Care Res. 2007; 57 (3): 533–537.Jacobs-Kosmin D., DeHoratius R.J. Calciphylaxis: An important imitator of cutaneous vasculitis. Arthritis Care Res. 2007; 57 (3): 533–537.Nigwekar S. U., Thadhani R., Brandenburg V. M. Calciphylaxis. N Engl J Med. 2018; 378 (18): 1704–1714.Nigwekar S. U., Thadhani R., Brandenburg V. M. Calciphylaxis. N Engl J Med. 2018; 378 (18): 1704–1714.Weenig R. H., Sewell L. D., Davis M. D., et al. Calciphylaxis: natural history, risk factor analysis, and outcome. J Am Acad Dermatol. 2007; 56 (4): 569–579.Weenig R. H., Sewell L. D., Davis M. D., et al. Calciphylaxis: natural history, risk factor analysis, and outcome. J Am Acad Dermatol. 2007; 56 (4): 569–579.Varga Z., Flammer A. J., Steiger P., et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020; 395 (10234): 1417–1418.Varga Z., Flammer A. J., Steiger P., et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020; 395 (10234): 1417–1418.Mondal R., Lahiri D., Deb S., et al. COVID-19: Are we dealing with a multisystem vasculopathy in disguise of a viral infection? J Thromb Thrombolysis. 2020; 50 (3): 567–579.Mondal R., Lahiri D., Deb S., et al. COVID-19: Are we dealing with a multisystem vasculopathy in disguise of a viral infection? J Thromb Thrombolysis. 2020; 50 (3): 567–579.Magro C., Mulvey J. J., Berlin D., et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases. Transl Res. 2020; 220: 1–13.Magro C., Mulvey J. J., Berlin D., et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases. Transl Res. 2020; 220: 1–13.Pickert A. An approach to vasculitis and vasculopathy. Cutis. 2012; 89 (5): E1– E3.Pickert A. An approach to vasculitis and vasculopathy. Cutis. 2012; 89 (5): E1– E3.Nakashima M. O., Rogers H.J. Hypercoagulable states: an algorithmic approach to laboratory testing and update on monitoring of direct oral anticoagulants. Blood Res. 2014; 49 (2): 85–94.Nakashima M. O., Rogers H.J. Hypercoagulable states: an algorithmic approach to laboratory testing and update on monitoring of direct oral anticoagulants. Blood Res. 2014; 49 (2): 85–94.Babalola O. A., Ogunkeyede A., Odetunde A. B., et al. Haematological indices of sickle cell patients with chronic leg ulcers on compression therapy. Afr J Lab Med. 2020; 9 (1): 1037.Babalola O. A., Ogunkeyede A., Odetunde A. B., et al. Haematological indices of sickle cell patients with chronic leg ulcers on compression therapy. Afr J Lab Med. 2020; 9 (1): 1037.Sackey D., Dei-Adomakoh Y., Olayemi E. Enhanced hypercoagulability in sickle cell anaemia patients with chronic leg ulcers. Adv Hematol. 2020; 2020: 5157031.Sackey D., Dei-Adomakoh Y., Olayemi E. Enhanced hypercoagulability in sickle cell anaemia patients with chronic leg ulcers. Adv Hematol. 2020; 2020: 5157031.Thornsberry L. A., LoSicco K. I., English J. C. The skin and hypercoagulable states. J Am Acad Dermatol. 2013; 69 (3): 450–462.Thornsberry L. A., LoSicco K. I., English J. C. The skin and hypercoagulable states. J Am Acad Dermatol. 2013; 69 (3): 450–462.Rayner R, Carville K, Keaton J, et al. Leg ulcers: atypical presentations and associated comorbidities. Wound Pract Res. 2009; 17: 168–185.Rayner R, Carville K, Keaton J, et al. Leg ulcers: atypical presentations and associated comorbidities. Wound Pract Res. 2009; 17: 168–185.Yotsu R. R., Suzuki K., Simmonds R. E., et al. Buruli ulcer: a review of the current knowledge. Curr Trop Med Rep. 2018; 5 (4): 247–256.Yotsu R. R., Suzuki K., Simmonds R. E., et al. Buruli ulcer: a review of the current knowledge. Curr Trop Med Rep. 2018; 5 (4): 247–256.Marques S. A., Abbade L. P. F. Severe bacterial skin infections. An Bras Dermatol. 2020; 95 (4): 407–417.Marques S. A., Abbade L. P. F. Severe bacterial skin infections. An Bras Dermatol. 2020; 95 (4): 407–417.Robson M. C., Heggers J. P. Bacterial quantification of open wounds. Mil Med. 1969; 134 (1): 19–24.Robson M. C., Heggers J. P. Bacterial quantification of open wounds. Mil Med. 1969; 134 (1): 19–24.Bowler P. G. The 10(5) bacterial growth guideline: reassessing its clinical relevance in wound healing. Ostomy Wound Manage, 2003; 49 (1): 44–53.Bowler P. G. The 10(5) bacterial growth guideline: reassessing its clinical relevance in wound healing. Ostomy Wound Manage, 2003; 49 (1): 44–53.Schultz G. S., Sibbald R. G., Falanga V., et al. Wound bed preparation: a systematic approach to wound management. Wound Repair Regen. 2003; 11 (Suppl 1): S1–S28.Schultz G. S., Sibbald R. G., Falanga V., et al. Wound bed preparation: a systematic approach to wound management. Wound Repair Regen. 2003; 11 (Suppl 1): S1–S28.Edwards R., Harding K. G. Bacteria and wound healing. Curr Opin Infect Dis. 2004; 17 (2): 91–96.Edwards R., Harding K. G. Bacteria and wound healing. Curr Opin Infect Dis. 2004; 17 (2): 91–96.Onesti M. G., Fioramonti P., Fino P., et al. Skin ulcer caused by venous extravasation of heroin. Int Wound J. 2014; 11 (4): 409– 411.Onesti M. G., Fioramonti P., Fino P., et al. Skin ulcer caused by venous extravasation of heroin. Int Wound J. 2014; 11 (4): 409– 411.Coull A., Sharp A. Understanding leg ulceration associated with intravenous drug use. Nursing Times [online]. 2018; 114 (6): 31–34.Coull A., Sharp A. Understanding leg ulceration associated with intravenous drug use. Nursing Times [online]. 2018; 114 (6): 31–34.Reynolds F. H., 2nd, Hong M. W., Banks S. L. Extensive skin necrosis from suspected levamisole-contaminated cocaine. Cutis. 2015; 96 (3): E15–E17.Reynolds F. H., 2nd, Hong M. W., Banks S. L. Extensive skin necrosis from suspected levamisole-contaminated cocaine. Cutis. 2015; 96 (3): E15–E17.Best P. J., Daoud M. S., Pittelkow M. R., Petitt R. M. Hydroxyurea-induced leg ulceration in 14 patients. Ann Intern Med. 1998; 128 (1): 29–32.Best P. J., Daoud M. S., Pittelkow M. R., Petitt R. M. Hydroxyurea-induced leg ulceration in 14 patients. Ann Intern Med. 1998; 128 (1): 29–32.Montefusco E., Alimena G., Gastaldi R., et al. Unusual dermatologic toxicity of long-term therapy with hydroxyurea in chronic myelogenous leukemia. Tumori. 1986; 72 (3): 317–21.Montefusco E., Alimena G., Gastaldi R., et al. Unusual dermatologic toxicity of long-term therapy with hydroxyurea in chronic myelogenous leukemia. Tumori. 1986; 72 (3): 317–21.Souza C. F., Suarez O. M., Silva T. F., et al. Ulcerations due to methotrexate toxicity in a psoriasis patient. An Bras Dermatol. 2016; 91 (3): 375–377.Souza C. F., Suarez O. M., Silva T. F., et al. Ulcerations due to methotrexate toxicity in a psoriasis patient. An Bras Dermatol. 2016; 91 (3): 375–377.Alaya Z., Mokni S., Guerfala M., et al. Acute severe cutaneous methotrexate toxicity in a patient with rheumatoid arthritis: Report of a rare side effect. Egyptian Rheumatol. 2018; 40 (4): 281–284.Alaya Z., Mokni S., Guerfala M., et al. Acute severe cutaneous methotrexate toxicity in a patient with rheumatoid arthritis: Report of a rare side effect. Egyptian Rheumatol. 2018; 40 (4): 281–284.Shawwa K., Alraiyes A. H., Eisa N., Alraies M. C. Cocaine-induced leg ulceration. BMJ Case Reports. 2013; 2013: bcr2013200507.Shawwa K., Alraiyes A. H., Eisa N., Alraies M. C. Cocaine-induced leg ulceration. BMJ Case Reports. 2013; 2013: bcr2013200507.Rodríguez Pichardo A., García Bravo B. Dermatitis artefacta: a review. Actas Dermosifiliogr. 2013; 104 (10): 854–866.Rodríguez Pichardo A., García Bravo B. Dermatitis artefacta: a review. Actas Dermosifiliogr. 2013; 104 (10): 854–866.Amr A., Schmitt C., Kuipers T., et al. Identifying and managing patients with factitious wounds. Adv Skin Wound Care. 2017; 30: 1–7.Amr A., Schmitt C., Kuipers T., et al. Identifying and managing patients with factitious wounds. Adv Skin Wound Care. 2017; 30: 1–7.Michet C. J., Whitelock C., Siparsky N. It takes a village: the management of extreme sequelae of skin popping. Wounds. 2021; 33 (1): 9–19.Michet C. J., Whitelock C., Siparsky N. It takes a village: the management of extreme sequelae of skin popping. Wounds. 2021; 33 (1): 9–19.Laughter M. R., Florek A. G., Wisell J., Newman S. Dermatitis artefacta, a form of factitial disorder imposed on self, misdiagnosed as pyoderma gangrenosum for eight years. Cureus. 2020; 12 (7): e9054.Laughter M. R., Florek A. G., Wisell J., Newman S. Dermatitis artefacta, a form of factitial disorder imposed on self, misdiagnosed as pyoderma gangrenosum for eight years. Cureus. 2020; 12 (7): e9054.Saha A., Seth J., Gorai S., Bindal A. Dermatitis artefacta: a review of five cases: a diagnostic and therapeutic challenge. Indian J Dermatol. 2015; 60 (6): 61–65.Saha A., Seth J., Gorai S., Bindal A. Dermatitis artefacta: a review of five cases: a diagnostic and therapeutic challenge. Indian J Dermatol. 2015; 60 (6): 61–65.Manna B, Cooper JS. Radiation Therapy Induced Skin Ulcer. StatPearls Publishing. 2021.Manna B, Cooper JS. Radiation Therapy Induced Skin Ulcer. StatPearls Publishing. 2021.Isbister G. K., Fan H. W. Spider bite. Lancet. 2011; 378 (9808): 2039–2047.Isbister G. K., Fan H. W. Spider bite. Lancet. 2011; 378 (9808): 2039–2047.Blättler W., Zimmet S. E. Compression therapy in venous disease. Phlebology. 2008; 23 (5): 203–205.Blättler W., Zimmet S. E. Compression therapy in venous disease. Phlebology. 2008; 23 (5): 203–205.Dini V., Romanelli M., Bertone M., et al. Improvement of idiopathic pyoderma gangrenosum during treatment with anti-tumor necrosis factor alfa monoclonal antibody. Int J Low Extrem Wounds. 2007; 6 (2): 108–113.Dini V., Romanelli M., Bertone M., et al. Improvement of idiopathic pyoderma gangrenosum during treatment with anti-tumor necrosis factor alfa monoclonal antibody. Int J Low Extrem Wounds. 2007; 6 (2): 108–113.González del Castillo J., Isernia V., Candel F. J., Martín-Sánchez F. J. Approach for initial treatment of skin and soft tissue infection. Clin Infect Dis. 2015; 60 (1): 169– 171.González del Castillo J., Isernia V., Candel F. J., Martín-Sánchez F. J. Approach for initial treatment of skin and soft tissue infection. Clin Infect Dis. 2015; 60 (1): 169– 171.Minniti C. P., Kato G. J. Critical reviews: how we treat sickle cell patients with leg ulcers. Am J Hematol. 2016; 91 (1): 22– 30.Minniti C. P., Kato G. J. Critical reviews: how we treat sickle cell patients with leg ulcers. Am J Hematol. 2016; 91 (1): 22– 30.Breuing K. H., Bayer L., Neuwalder J., Orgill D. P. Early experience using low-frequency ultrasound in chronic wounds. Ann Plast Surg. 2005; 55 (2): 183–187.Breuing K. H., Bayer L., Neuwalder J., Orgill D. P. Early experience using low-frequency ultrasound in chronic wounds. Ann Plast Surg. 2005; 55 (2): 183–187.Hoppe I. C., Granick M. S. Debridement of chronic wounds: a qualitative systematic review of randomized controlled trials. Clin Plast Surg. 2012; 39 (3): 221– 228.Hoppe I. C., Granick M. S. Debridement of chronic wounds: a qualitative systematic review of randomized controlled trials. Clin Plast Surg. 2012; 39 (3): 221– 228.Madhok B. M., Vowden K., Vowden P. New techniques for wound debridement. Int Wound J. 2013; 10 (3): 247–251.Madhok B. M., Vowden K., Vowden P. New techniques for wound debridement. Int Wound J. 2013; 10 (3): 247–251.Wolcott R. D., Kennedy J. P, Dowd S. E. Regular debridement is the main tool for maintaining a healthy wound bed in most chronic wounds. J Wound Care. 2009; 18 (2): 54–56.Wolcott R. D., Kennedy J. P, Dowd S. E. Regular debridement is the main tool for maintaining a healthy wound bed in most chronic wounds. J Wound Care. 2009; 18 (2): 54–56.Boateng J., Catanzano O. Advanced therapeutic dressings for effective wound healing — A review. J Pharm Sci. 2015; 104 (11): 3653–3680.Boateng J., Catanzano O. Advanced therapeutic dressings for effective wound healing — A review. J Pharm Sci. 2015; 104 (11): 3653–3680.Beiteke U., Bigge S., Reichenberger C., et al. Pain and pain management in dermatology. J Dtsch Dermatol Ges. 2015; 13 (10): 967–987.Beiteke U., Bigge S., Reichenberger C., et al. Pain and pain management in dermatology. J Dtsch Dermatol Ges. 2015; 13 (10): 967–987.Adderley U. J, Holt I. G. Topical agents and dressings for fungating wounds. Cochrane Database Syst Rev. 2014; 15 (5): CD003948.Adderley U. J, Holt I. G. Topical agents and dressings for fungating wounds. Cochrane Database Syst Rev. 2014; 15 (5): CD003948.Quattrone F., Dini V., Barbanera S., et al. Cutaneous ulcers associated with hydroxyurea therapy. J Tissue Viability. 2013; 22 (4): 112–121.Quattrone F., Dini V., Barbanera S., et al. Cutaneous ulcers associated with hydroxyurea therapy. J Tissue Viability. 2013; 22 (4): 112–121.Sunderkötter C., Bonsmann G., Sindrilaru A., et al. Management of leukocytoclastic vasculitis. J Dermatolog Treat. 2005; 16 (4): 193– 206.Sunderkötter C., Bonsmann G., Sindrilaru A., et al. Management of leukocytoclastic vasculitis. J Dermatolog Treat. 2005; 16 (4): 193– 206.Linares M. A., Zakaria A., Nizran P. Skincancer. Prim Care. 2015; 42 (4): 645–659.Linares M. A., Zakaria A., Nizran P. Skincancer. Prim Care. 2015; 42 (4): 645–659.Hussein M. R. Skin metastasis: a pathologist’s perspective. J Cutan Pathol. 2010; 37 (9): e1–e20.Hussein M. R. Skin metastasis: a pathologist’s perspective. J Cutan Pathol. 2010; 37 (9): e1–e20.Driver V. R., Yao M., Miller C. J. Noncontact low-frequency ultrasound therapy in the treatment of chronic wounds: a meta-analysis. Wound Repair Regen. 2011; 19 (4): 475– 480.Driver V. R., Yao M., Miller C. J. Noncontact low-frequency ultrasound therapy in the treatment of chronic wounds: a meta-analysis. Wound Repair Regen. 2011; 19 (4): 475– 480.Barnes R., Shahin Y., Gohil R., Chetter I. Electrical stimulation vs. standard care for chronic ulcer healing: a systematic review and meta-analysis of randomised controlled trials. Eur J Clin Invest. 2014; 44 (4): 429–440.Barnes R., Shahin Y., Gohil R., Chetter I. Electrical stimulation vs. standard care for chronic ulcer healing: a systematic review and meta-analysis of randomised controlled trials. Eur J Clin Invest. 2014; 44 (4): 429–440.Dai T., Vrahas M. S., Murray C. K, Hamblin M. R. Ultraviolet C irradiation: an alternative antimicrobial approach to localized infections? Research Support, N.I.H., Extramural Research Support, U.S. Gov’t, Non-P.H.S. Review. Expert Rev Anti Infect Ther. 2012; 10 (2): 185–195.Dai T., Vrahas M. S., Murray C. K, Hamblin M. R. Ultraviolet C irradiation: an alternative antimicrobial approach to localized infections? Research Support, N.I.H., Extramural Research Support, U.S. Gov’t, Non-P.H.S. Review. Expert Rev Anti Infect Ther. 2012; 10 (2): 185–195.Situm M., Kolić M. Atypical wounds: definition and classification. Acta Med Croatica. 2012; 66 (Suppl 1): 5–11.Situm M., Kolić M. Atypical wounds: definition and classification. Acta Med Croatica. 2012; 66 (Suppl 1): 5–11.

The authors declare that there are no conflicts of interest present.